Radiotherapy and Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.8 | Q1 | 89.9% | 2.076 | Q1 | 95.6% |
| 2024 | 5.3 | Q1 | 90.2% | 1.738 | Q1 | 94.0% |
| 2023 | 4.9 | Q1 | 90.5% | 1.702 | Q1 | 94.1% |
| 2022 | 5.7 | Q1 | 91.0% | 1.834 | Q1 | 95.0% |
| 2021 | 6.9 | Q1 | 89.1% | 1.946 | Q1 | 95.7% |
| 2020 | — | — | 1.892 | Q1 | 95.0% | |
| 2019 | — | — | 2.003 | Q1 | 95.6% | |
| 2018 | — | — | 2.023 | Q1 | 95.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0167-8140
ISSN
1879-0887
region
Western Europe
coverage
1983-2026